Publications by authors named "Pilei Si"

Claim this Profile
A
A Nanomodulator Enhances Radiotherapy-Induced In Situ Cancer Vaccine by Promoting Antigen-Presenting of Tumor-Associated Macrophage.
Xiu Zhao, Mengli Li, Jun Li, Yueying Han, Yu Gong, Pilei Si

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum urate levels, gout and breast cancer: observational and Mendelian randomization analyses.
Shuai Wang, Zhiyuan Zhang, Yuqing Su, Shoukai Wang, Wenwen Li, Pilei Si

Transl Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways.
Yu Zhang, Ningjie Guo, Haoyi Zhu, Mengyang Liu, Jiahui Hao, Pilei Si

Theranostics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell-Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes.
Lei Zhou, Ling Zhao, Mengyao Wang, Xu Qi, Xin Zhang, Pilei Si

Adv Sci (Weinh)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.
Sijie Wang, Na Yin, Yongjuan Li, Tingting Xiang, Wenxiao Jiang, Pilei Si

J Nanobiotechnology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen-independent alkyl radical nanogenerator enhances breast cancer therapy.
Pilei Si, Wenyan Yu, Chengzhen Li, Haijun Chen, Enzhao Zhang

Nanomedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.
Sijie Wang, Na Yin, Yongjuan Li, Tingting Xiang, Wenxiao Jiang, Pilei Si

J Nanobiotechnology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC-1 recognition-based activated drug nanoplatform improves doxorubicin chemotherapy in breast cancer.
Pilei Si, Jinjin Shi, Pei Zhang, Cao Wang, Haijun Chen

Cancer Lett· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer.
Pilei Si, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang

Cancer Biomark· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 exon 27 mutations predict worse survival of breast cancer patients, especially in HER2-negative patients.
Pilei Si, Tao Chen, Bin Fang, Jiabing Yao, Gaoxiu Liu

Cancer Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.
Pilei Si, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang

Oncol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis